Recon: FDA grants accelerated approval to Padcev/Keytruda combo for bladder cancer; Gossamer’s lymphoma trial put on hold following patient deaths
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy